CD200R1 antag 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
23ME-00610 / 23andMe
23ME-00610-CLIN-001, NCT05199272: A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Active, not recruiting
1/2
141
Canada, US
23ME-00610
23andMe, Inc.
Solid Tumor, Clear Cell Renal Cell Carcinoma, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Neuroendocrine Tumors, MSI-H Cancer, Cancer With A High Tumor Mutational Burden, Extensive-stage Small-cell Lung Cancer
03/25
03/25
HBM1047 / Harbour BioMed
No trials found

Download Options